Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Themis Medicare Limited ( (IN:THEMISMED) ) has provided an update.
Themis Medicare Limited announced the appointment of Ms. Neha Thakore as an Independent Director and Mr. Viraj Save as Executive President of Sales & Marketing, effective August 1, 2025. These appointments are part of the company’s strategic efforts to strengthen its leadership team and enhance its market position. Additionally, the company approved its unaudited financial results for the quarter ending June 30, 2025, and set a record date for determining dividend entitlements, indicating a focus on financial transparency and shareholder value.
More about Themis Medicare Limited
Themis Medicare Limited operates in the pharmaceutical industry, specializing in Active Pharmaceutical Ingredients (API) and other pharmaceutical products. The company focuses on strategic growth and sustainability, with a strong emphasis on corporate governance and industry development.
Average Trading Volume: 16,949
Technical Sentiment Signal: Sell
Current Market Cap: 9.89B INR
Learn more about THEMISMED stock on TipRanks’ Stock Analysis page.